Casgevy: Key Insights Into the First-Ever CRISPR Gene-Editing Therapy Approved for Sickle Cell Disease
Medicine regulators greenlight the first CRISPR therapy, Casgevy, for genetic blood disorders. Explore its approval, mechanism, and details in this article.
Source: sciencetimes.com